Rategain Travel Technologies Limited (RATEGAIN) — Announcement

📢 Key Event
RateGain approves grant of 116,631 SARs under 2022 scheme

🔄 What Changed
First SAR grant approved under 2022 scheme

🔮 What's Next
Vesting within three years of vesting schedule

💡 Investor Takeaway
SARs offer retention benefits but introduce future dilution risk for shareholders.

⚠️ Risks
Future equity dilution upon SAR exercise

RateGain Travel Technologies announced on May 20, 2026 that its Nomination and Remuneration Committee approved the grant of 116,631 stock appreciation rights (SARs) under the 2022 scheme, with three separate tranches priced at Rs. 466.75, Rs. 493.75, and Rs. 592.50 per unit, vesting over four years with a 10-20-30-40 schedule and exercisable within three years of vesting. This marks the company's first formal SAR issuance, expanding its employee compensation framework beyond traditional ESOPs. The move aligns with SEBI's share-based employee benefits regulations and reflects a strategic shift toward performance-linked long-term incentives, potentially enhancing retention without immediate cash outflow. Investors should note that while no financial dilution occurs upon exercise, the SARs introduce future equity dilution risk and signal confidence in long-term share price growth.

📄 View Original Announcement (PDF)

📊 Stock Analysis — RATEGAIN ✨ Ask AI About This